Literature DB >> 31520801

Intravenous immunoglobulin efficacy for primary Sjögren's Syndrome associated small fiber neuropathy.

Antoine Gaillet1, Karine Champion2, Jean-Pascal Lefaucheur3, Hervé Trout4, Jean-François Bergmann1, Damien Sène5.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31520801     DOI： 10.1016/j.autrev.2019.102387

Source DB:  PubMed          Journal:  Autoimmun Rev        ISSN： 1568-9972            Impact factor:   9.754


× No keyword cloud information.
  5 in total

Review 1.  Small Fiber Neuropathy.

Authors:  N Strand; C Wie; J Peck; M Maita; N Singh; J Dumbroff; V Tieppo Francio; M Murphy; K Chang; D M Dickerson; J Maloney
Journal:  Curr Pain Headache Rep       Date:  2022-04-06

2.  Association of small-fiber polyneuropathy with three previously unassociated rare missense SCN9A variants.

Authors:  Mary A Kelley; Anne Louise Oaklander
Journal:  Can J Pain       Date:  2020-02-05

3.  Peripheral Nervous System Involvement in Sjögren's Syndrome: Analysis of a Cohort From the Italian Research Group on Sjögren's Syndrome.

Authors:  Giacomo Cafaro; Carlo Perricone; Francesco Carubbi; Chiara Baldini; Luca Quartuccio; Roberta Priori; Onorina Berardicurti; Francesco Ferro; Saviana Gandolfo; Angelica Gattamelata; Roberto Giacomelli; Salvatore De Vita; Roberto Gerli; Elena Bartoloni
Journal:  Front Immunol       Date:  2021-03-24       Impact factor: 7.561

4.  Maintenance therapy with subcutaneous immunoglobulin in a patient with immune-mediated neuropathic postural tachycardia syndrome.

Authors:  Kalliopi Pitarokoili; Andrea Maier; Elena C de Moya Rubio; Katrin Hahn; Gerd Wallukat; Diamantis Athanasopoulos; Thomas Grüter; Jeremias Motte; Anna Lena Fisse; Ralf Gold
Journal:  J Transl Autoimmun       Date:  2021-08-14

5.  Intravenous Immunoglobulin Therapy in Patients With Painful Idiopathic Small Fiber Neuropathy.

Authors:  Margot Geerts; Bianca T A de Greef; Maurice Sopacua; Sander M J van Kuijk; Janneke G J Hoeijmakers; Catharina G Faber; Ingemar S J Merkies
Journal:  Neurology       Date:  2021-03-25       Impact factor: 9.910
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.